Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravindra Mehta

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
International Journal of Molecular Sciences|April 3, 2021
Urinary Exosomes Identify Inflammatory Pathways in Vancomycin Associated Acute Kidney InjuryLinda Awdishu, Amy Le, Jordan Amato, et al.
Journal of Critical Care|April 3, 2025
Renal replacement therapy modalities and techniques in intensive care units: An international surveyCéline Monard, Arnaud Marel, Michael Joannidis, et al.
American Heart Journal|December 24, 2018
The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarctionC Michael Gibson, Mathieu Kerneis, Megan K Yee, et al.
Critical Care (London, England)|March 22, 2024
Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trialsMatthieu Legrand, Sean M Bagshaw, Pavan K Bhatraju, et al.
Kidney International|September 16, 2011
Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)Gary R Matzke, George R Aronoff, Arthur J Atkinson, et al.
JAMA Network Open|October 6, 2020
Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference: A Consensus StatementMarlies Ostermann, Alexander Zarbock, Stuart Goldstein, et al.
Kidney360|August 8, 2025
Proceedings of the UAB CRRT Academy (2023-2024): Managing De-Escalation of Acute RRT and Optimizing Drug Dosing During RRT TransitionsWilliam Beaubien-Souligny, Melissa Thompson Bastin, J Pedro Teixeira, et al.
Lung India : Official Organ of Indian Chest Society|July 2, 2024
Expert panel opinion on adult pneumococcal vaccination in the post-COVID era (NAP- EXPO Recommendations-2024)Parvaiz A Koul, Agam C Vora, Surinder K Jindal, et al.
The Lancet. Infectious Diseases|April 7, 2022
Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, IndiaValliappan Muthu, Ritesh Agarwal, Atul Patel, et al.
Intensive Care Medicine|March 4, 2024
Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)Peter Pickkers, Derek C Angus, Kristie Bass, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
International Journal of Molecular Sciences|April 3, 2021
Urinary Exosomes Identify Inflammatory Pathways in Vancomycin Associated Acute Kidney InjuryLinda Awdishu, Amy Le, Jordan Amato, et al.
Journal of Critical Care|April 3, 2025
Renal replacement therapy modalities and techniques in intensive care units: An international surveyCéline Monard, Arnaud Marel, Michael Joannidis, et al.
American Heart Journal|December 24, 2018
The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarctionC Michael Gibson, Mathieu Kerneis, Megan K Yee, et al.
Critical Care (London, England)|March 22, 2024
Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trialsMatthieu Legrand, Sean M Bagshaw, Pavan K Bhatraju, et al.
Kidney International|September 16, 2011
Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)Gary R Matzke, George R Aronoff, Arthur J Atkinson, et al.
JAMA Network Open|October 6, 2020
Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference: A Consensus StatementMarlies Ostermann, Alexander Zarbock, Stuart Goldstein, et al.
Kidney360|August 8, 2025
Proceedings of the UAB CRRT Academy (2023-2024): Managing De-Escalation of Acute RRT and Optimizing Drug Dosing During RRT TransitionsWilliam Beaubien-Souligny, Melissa Thompson Bastin, J Pedro Teixeira, et al.
Lung India : Official Organ of Indian Chest Society|July 2, 2024
Expert panel opinion on adult pneumococcal vaccination in the post-COVID era (NAP- EXPO Recommendations-2024)Parvaiz A Koul, Agam C Vora, Surinder K Jindal, et al.
The Lancet. Infectious Diseases|April 7, 2022
Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, IndiaValliappan Muthu, Ritesh Agarwal, Atul Patel, et al.
Intensive Care Medicine|March 4, 2024
Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)Peter Pickkers, Derek C Angus, Kristie Bass, et al.
Pageof 9